SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aviron
AVIR 3.065+1.2%Nov 26 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nelli who wrote (15)7/15/1997 9:02:00 PM
From: STEVE   of 645
 
To All,

I'm one of those who wanted to jump into Aviron early today but
thought the stock is already richly valued considering that the
company is still losing money.

I guess what is lost in all the excitement is the little known
information about Medeva PLC (NY:MDV, 17-1/2) which recently signed
a commercial supply agreement with Aviron, see
biz.yahoo.com. Medeva
manufactured the vaccine used in Aviron's trials. Instead of joining
the fray into Aviron, wouldn't it be a wise move to buy Medeva PLC
instead which is a profitable company?

Regards,

Steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News